Muscular Dystrophy, Duchenne: all 480 studies

Page 5 of 5. Open to participants first (109), then studies with results posted, then the rest; newest registration first within each.

• Magnetic Resonance and Optical Imaging of Dystrophic and Damaged MuscleCompletedNCT02168114Not applicable
• Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2ICompletedNCT02165358
• Effects of Sodium Nitrate on Blood Flow in Becker Muscular DystrophyCompletedNCT02147639Phase 2/3
• Evaluation of Muscle miRNA as Biomarkers in DystrophinopathiesStatus unknownNCT02109692Not applicable
• Exploratory Study of NS-065/NCNP-01 in DMDCompletedNCT02081625Phase 1
• IRM Cardiaque en Respiration Libre Pour Des Patients Atteints de Dystrophinopathie sévèreCompletedNCT02078076Not applicable
• A Phase 1b Study of SMT C1100 in Subjects With Duchenne Muscular Dystrophy (DMD)CompletedNCT02056808Phase 1
• A Trial of Chronotherapy of Corticosteroids in Duchenne Muscular DystrophyWithdrawnNCT02036463Phase 2
• Peak Cough Flow and Cough Clearance in Patients With Muscular DystrophyCompletedNCT02034305
• L-citrulline and Metformin in Becker's Muscular DystrophyCompletedNCT02018731Phase 2
• L-citrulline and Metformin in Duchenne's Muscular DystrophyCompletedNCT01995032Phase 3
• Optimum Insufflation Capacity in NMDCompletedNCT01981915Not applicable
• Open Label Extension Study of HT-100 in Patients With DMDTerminatedNCT01978366Phase 2
• Duchenne Muscular Dystrophy < 18y in Norway: Genotype/Phenotype, Growth, Puberty, Bone Health and Quality of Life.CompletedNCT01963897
• A Phase I/II Study of BMN053 in Subjects With Duchenne Muscular Dystrophy (DMD)TerminatedNCT01957059Phase 1/2
• Whole Body Vibration Therapy in Boys With Duchenne Muscular DystrophyCompletedNCT01954940Not applicable
• At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
• Mother-caregivers of Children With Duchenne Muscular DystrophyCompletedNCT01921374Not applicable
• Phase II Study of NPC-14 (Arbekacin Sulfate) to Explore Safety, Tolerability, and Efficacy in Duchenne Muscular DystrophyStatus unknownNCT01918384Phase 2
• Drisapersen Duchenne Muscular Dystrophy (DMD) Treatment ProtocolWithdrawnNCT01890798Phase 3
• Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular DystrophyTerminatedNCT01847573Phase 1/2
• Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy.Status unknownNCT01834066Phase 1/2
• Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular DystrophyStatus unknownNCT01834040Phase 1/2
• Phase IIb Study of PRO045 in Subjects With Duchenne Muscular DystrophyTerminatedNCT01826474Phase 1/2
• Endomysial Fibrosis, Muscular Inflammatory Response and Calcium Homeostasis Dysfunction in Duchenne Muscular DystrophyStatus unknownNCT01823783Not applicable
• Duchenne Muscular Dystrophy Tissue Bank for Exon SkippingStatus unknownNCT01772043
• A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.TerminatedNCT01753804
• Myocardial Involvement in Carriers of Duchenne Muscular Dystrophy: An MRI-studyCompletedNCT01712152
• Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular DystrophyCompletedNCT01648634Phase 3
• Pediatric Radio Frequency Coils GenericActive, not recruitingNCT01633866
• Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular DystrophyStatus unknownNCT01610440Phase 1/2
• PDE Inhibitors in DMD Study (Acute Dosing Study)CompletedNCT01580501Phase 1
• CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic CarriersCompletedNCT01540604Phase 2
• Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon SkippingStatus unknownNCT01539772
• Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body MyositisCompletedNCT01519349Phase 1
• Double Push Acoustic Radiation Force (DP ARF) Ultrasound for Monitoring Degeneration in Duchenne Muscular DystrophyCompletedNCT01506518
• Electrical Impedance Myography and Ultrasound as Biomarkers of Duchenne Muscular DystrophyCompletedNCT01491555
• Open Label Study of GSK2402968 in Subjects With Duchenne Muscular DystrophyTerminatedNCT01480245Phase 3
• To Compare the Pharmacokinetics Profiles of ISO 20, IBU 200 and IBU Plus ISO Combinations 200 + 20CompletedNCT01478022Phase 1
• Studying Skeletal Muscle, Heart, and Diaphragm Imaging in Boys With Duchenne Muscular DystrophyCompletedNCT01451281
• Safety, Tolerability and Effects of L-Arginine in Boys With Dystrophinopathy on CorticosteroidsCompletedNCT01388764Phase 1
• The Role of Family Functioning in Promoting Adaptation in Siblings of Individuals With Duchenne Muscular Dystrophy (DMD)TerminatedNCT01386515
• Observational Study of Patients With Duchenne Muscular Dystrophy Theoretically Treatable With Exon 53 SkippingStatus unknownNCT01385917
• Research of Biomarkers in Duchenne Muscular Dystrophy PatientsCompletedNCT01380964
• Tadalafil and Sildenafil for Duchenne Muscular DystrophyCompletedNCT01359670Early Phase 1
• Effect of Modulating the nNOS System on Cardiac, Muscular and Cognitive Function in Becker Muscular Dystrophy PatientsCompletedNCT01350154Phase 2
• Safety Study of Flavocoxid in Duchenne Muscular DystrophyCompletedNCT01335295Phase 1
• Extension Study of ACE-031 in Subjects With Duchenne Muscular DystrophyTerminatedNCT01239758Phase 2
• Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular DystrophyCompletedNCT01183767Phase 2/3
• The PTC124 (Ataluren) Clinical Trial for Duchenne Muscular Dystrophy: Exploration of the Experiences of Parents, Clinician Researchers, and the Industry SponsorCompletedNCT01182324
• Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular DystrophyCompletedNCT01153932Phase 2
• Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular DystrophiesCompletedNCT01126697Phase 2/3
• Comparative Study of Clinical Endpoint in DMD: Handheld Myometry (HHM) Versus CINRG Quantitative Measurement System (CQMS)CompletedNCT01125709
• This is a Study to Get More Information About Non Ambulatory Boys & Men With Duchenne Muscular DystrophyCompletedNCT01098708
• Cardiac Magnetic Resonance in Children With Muscular DystrophyCompletedNCT01081080
• Tadalafil in Becker Muscular DystrophyCompletedNCT01070511Phase 4
• Cardiac Outcome Measures in Children With Muscular DystrophyCompletedNCT01066455
• Evaluation of Limb-Girdle Muscular DystrophyCompletedNCT00893334
• Evaluation of a Mechanical Device During Acute Respiratory Failure in Patients With Neuromuscular DisordersTerminatedNCT00839033Phase 3
• Ramipril Versus Carvedilol in Duchenne and Becker PatientsStatus unknownNCT00819845Phase 4
• Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)CompletedNCT00758225Phase 2
• Metformin in Children With Motor DeficitCompletedNCT00720161Not applicable
• The Preventive Efficacy of Carvedilol on Cardiac Dysfunction in Duchenne Muscular DystrophyStatus unknownNCT00606775Phase 4
• Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD)Status unknownNCT00468832
• Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop CodonsCompletedNCT00451074Phase 1
• Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular DystrophyCompletedNCT00428935Phase 1
• Biomechanical Analysis of Gait in Individuals With Duchenne Muscular DystrophyCompletedNCT00312247
• Effect of Oral Glutamine on Muscle Mass and Function in Duchenne Muscular DystrophyCompletedNCT00296621Phase 2
• Safety and Efficacy Study of PTC124 in Duchenne Muscular DystrophyCompletedNCT00264888Phase 2
• Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular DystrophyCompletedNCT00243789Phase 1/2
• Test-Retest Reliability of Pulmonary Function Tests in Patients With Duchenne's Muscular DystrophyWithdrawnNCT00207857
• High-dose Prednisone in Duchenne Muscular DystrophyCompletedNCT00110669Phase 3
• Study Evaluating MYO-029 in Adult Muscular DystrophyCompletedNCT00104078Phase 1/2
• Pentoxifylline in Duchenne Muscular DystrophyCompletedNCT00102453Phase 1/2
• KUL0401: An Open-label Pilot Study of Oxatomide in Steroid-Naive Duchenne Muscular DystrophyCompletedNCT00033813Phase 2
• An Open-label Pilot Study of Coenzyme Q10 in Steroid-Treated Duchenne Muscular DystrophyCompletedNCT00033189Phase 2
• A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD)CompletedNCT00018109Phase 3
• Creatine and Glutamine in Steroid-Naive Duchenne Muscular DystrophyCompletedNCT00016653Phase 2/3
• Gentamicin Treatment of Muscular DystrophyCompletedNCT00005574Phase 1
• Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular DystrophyCompletedNCT00004646Phase 3

← Muscular Dystrophy, Duchenne overview